期刊文献+

血清CEA和CA125水平对间质性肺病癌变的早期诊断学研究 被引量:3

Diagnostic value of CEA and CA125 in patient with interstitial lung disease complicated with lung cancer
下载PDF
导出
摘要 目的比较ILD患者和ILD合并肺癌患者血清CEA和CA125的水平,探讨其在ILD合并肺癌早期诊断中的临床应用价值。方法设置ILD合并肺癌组(n=42)、ILD组(n=70)和对照组(n=60),测定并比较两组患者血清CEA和CA125的水平,通过受试者工作曲线评价CEA和CA125对ILD合并肺癌的诊断价值。结果 ILD合并肺癌组血清CEA、CA125水平均高于ILD组和对照组(P〈0.05);ILD组血清CEA、CA125水平均高于对照组(P〈0.05);血清CEA和CA125在诊断ILD合并肺癌的曲线下面积(area under curve,AUC)分别为0.722(95%CI:0.633-0.769,P〈0.05),0.751(95%CI:0.658-0.791,P〈0.05)。当血清CEA为6.2 ng/m L时,其诊断的敏感度为72.3%,特异度为69.2%;当血清CA125为60.4U/m L时,其诊断的敏感度为75.3%,特异度为79.7%。结论 ILD合并肺癌患者血清CEA和CA125较ILD患者要高,血清CEA和CA125对ILD合并肺癌的早期诊断具有参考价值。 Objective To investigate the diagnostic value of CEA and CA125 in patient with interstitial lung disease( ILD) complicated with lung cancer. Methods The serum levels of CEA and CA125 were detected in 42 patients with ILD complicated with lung cancer,70 patients with ILD only and 60 patients with common pneumonia.Receiver operating characteristic( ROC) curve was used to estimate the CEA and CA125 diagnostic value of ILD complicated with lung cancer. Results The serum levels of CEA and CA125 were higher in ILD complicated with lung cancer patients than in those with ILD( P〈0.05) and the control group( P〈0.05). ROC curve analysis showed a cut-off point of 6. 2 ng / m L for CEA and 60. 4 U / m L for CA125 with sensitivities of 72. 3% and75. 3%,specificities of 69. 2% and 79. 7%,and the areas under the curve( AUC) were 0. 722( 95% CI: 0. 633 - 0. 769,P〈0.05) and 0. 751( 95% CI: 0. 658 - 0. 791,P〈0.05) respectively. Conclusion The levels of serum CEA and CA125 increases in ILD complicated with lung cancer patients,which can be used as tumor markers for the early diagnosis of lung cancer.
作者 张静 张振安
出处 《临床肺科杂志》 2015年第5期825-828,共4页 Journal of Clinical Pulmonary Medicine
关键词 间质性肺病 肺癌 癌胚抗原 癌抗原CA125 interstitial lung disease lung cancer CEA CA125
  • 相关文献

参考文献14

  • 1Sverzellati N,Guerci L,Randi G,et al.Interstitial lung diseases in a lung cancer screening trial[J].The European respiratory journal,2011,38(2):392-400.
  • 2马丽媛,王金华,刘颖.联合检测血清CEA、CA125在肺癌早期诊断中的意义[J].国际检验医学杂志,2014,35(10):1360-1361. 被引量:5
  • 3American Thoracic Society;European Respiratory Society.American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias.This joint statement of the American Thoracic Society(ATS),and the European Respiratory Society(ERS)was adopted by the ATS board of directors,June 2001 and by the ERS Executive Committee,June 2001[J].Am J Respir Crit Care med,2002,165:277-304.
  • 4Bestaev DV,Karateev DE,Nasonov EL.Diagnosis and problems in therapy of interstitial lung disease associated with rheumatoid arthritis[J].Ter Arkhiv,2013,85(5):84-91.
  • 5翟亮.几种间质性肺病和肺癌的关系[J].医学理论与实践,2013,26(8):1006-1009. 被引量:5
  • 6Bouros D,Hatzakis K,Labrakis H,et al.Association of malignancy with diseases causing interstitial pulmonary changes[J].Chest,2002,121:1278-1289.
  • 7刘健群,代华平.间质性肺疾病与肺癌[J].国际呼吸杂志,2011,31(22):1741-1745. 被引量:3
  • 8Miyazaki K,Satoh H,Kurishima K,et al.Interstitial lung disease in patients with small cell lung cancer[J].Med Oncol,2010,27(3):763-767.
  • 9King JD,Casavant BP,Lang JM.Rapid translation of circulating tumor cell biomarkers into clinical practice:technology development,clinical needs and regulatory requirements[J].Lab on a chip,2014,14(1):24-31.
  • 10Duffy MJ,Lamerz R,Haglund C,et al.Tumor markers in colorectal cancer,gastric cancer and gastrointestinal stromal cancers:European group on tumor markers 2014 guidelines update[J].International journal of cancer Journal international du cancer,2014,134(11):2513-2522.

二级参考文献117

共引文献18

同被引文献27

  • 1Zhang Y, Yu LK, Lu GJ, et al. Prognostic values of VEGF and endostatin with malignant pleural effusions in patients with lung cancer[ ] ]. Asian Pac J Cancer Prey, 2014 ; 15 (19) :8435 - 40.
  • 2Zhou WB, Bal M, Jin Y. Diagnostic value of vascular endothelial growth factor and endostatin in malignant pleural effusions[ J]. Int J Tubere Lung Dis. 2009,13(3) :381 -386.
  • 3Pichelmayer O, Gruenberger B, Zielinski C, et al. Bevacizumab is active in malignant effusion [J]. Ann Oncol, 2006, 17(12) : 1853.
  • 4Venneri MA, De Palma M, Ponzoni M, et al. Identification of proangiogenic TIE2-expressing monoeytes (TEMs) in human pe- ripheral blood and cancer [ J ]. Blood, 2007,109 ( 12 ) : 5276 - 5285.
  • 5Tomimoto H, Yano S, Mugnruma H, et al. Levels of soluble vascular endothelial growth factor receptor 1 are elevated in the exudative pleural effusions[J]. J Med Invest,2007,54(1-2) :146- 153.
  • 6Kalomenidis I, Kollintza A, Sigala I, et al. Angiopoietin-2 levels are elevated in exudative pleural effusions [ J ]. Chest, 2006 ; 129 (5) :1259-66.
  • 7Hashizume H, Falc6n BL, Kuroda T, et al. Complementary actions of inhibitors of angiopoietin-2 and VEGF on tumor angiogenesis and growth[J]. Cancer Res,2010,70(6) :2213 -2223.
  • 8Koh YJ, Kim HZ, Hwang St, et al. Double antiangiogenic protein, DAAP, targeting VEGF-A and angiopoietins in tumor angiogenesis, metastasis, and vascular leakage [ J ]. Cancer Cell, 2010,18 ( 2 ) : 171 - 184.
  • 9Shoji F, Yoshino I, Yano T, et al. Serum carcino-embryonic anti- gen level is associated with epidermal growth factor receptor muta- tions in recurrent lung adenocarcinomas [ J ]. Cancer, 2007, 110 (12) : 2793 -2798.
  • 10Jung M, Kim SH, Lee Y J, et al. Prognostic and predictive value of CEA and CYFRA21-1 levels in advanced non-small cell lung canc- er patients treated with gefitinib or edotinib [ J ]. Exp Ther Med,2011,2(4):685 -693.

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部